WNT3A and Anxiety: WNT3A-treated mice showed reduced anxiety levels based on the elevated-plus maze paradigm and marble-burying test (Fig. 5b,c and Extended Data Fig. 10a), which indicated that transient WNT–β-catenin activation during embryonic brain development mimics the ID caused by KDM5C mutations.